mmpc - National Indian Health Board

RRIAR
Ref.
#
2.c.
2.d.
3.a.
Short Title/
Current Status of Regulation/
Title/
Agency
Medicare Advantage and PDP
Data Requirements
ACTION: Request for Comment
NOTICE: Application for New and
Expanding Medicare Prescription
Drug Plans and Medicare
Advantage Prescription Drug (MA-
PD) Plans, including Cost Plans
and Employer Group Waiver Plans
AGENCY: CMS
Medicare Advantage and PDP
Plan Applications
ACTION: Request for Comment
NOTICE: Part C Medicare
Advantage and 1876 Cost Plan
Expansion Application
AGENCY: CMS
Medicare Part B Rates
ACTION: Final Rule
NOTICE: Medicare Program;
Payment Policies Under the
Physician Fee Schedule and Other
Revisions to Part B for CY 2011
AGENCY: CMS
TABLE A: REGULATIONS INCLUDED TO DATE IN RRIAR TABLES B AND C
UPDATED THROUGH 11/9/2012
File Code
Dates (Issue, Due, File,
Subsequent Action)
CMS-10137 Issue Date: 7/6/2012
Due Date: 9/4/2012
NIHB File Date: None
Date of Subsequent Agency
Action, if any:
CMS-10237
and CMS-
10137
CMS-2010-
0205-0002
Issue Date: 10/12/2012
Due Date: 11/13/2012
NIHB File Date: Under review.
Date of Subsequent Agency
Action, if any:
Issue Date: 7/13/2010
Due Date: 8/24/2010
NIHB File Date: None
Date of Subsequent Agency
Action, if any: Issued Final Rule
11/29/2010
In Table B--
Is the summary of
Agency action
included?
Is the NIHB analysis
included?
Summary of Agency
action: √
NIHB analysis of
action: None.
Summary of Agency
action: [To be
entered.]
NIHB analysis of
action: [To be
entered.]
Summary of Agency
action: √
NIHB analysis of
action: None.
In Table C--
Is the list of NIHB
recommendations included?
Has the Agency taken subsequent
action?
Is an analysis of subsequent
Agency action included?
NIHB recommendations included:
Subsequent Agency action:
Analysis of Agency action:
NIHB recommendations included:
Subsequent Agency action:
Analysis of Agency action:
NIHB recommendations included:
Subsequent Agency action:
Analysis of Agency action:
: regulation review complete : regulation currently under review : regulation release pending
National Indian Health Board, Regulation Review and Impact Analysis Report Page 10 of 38 11/12/2012